Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8423) 8423
Magazine Article (9) 9
Book / eBook (6) 6
Book Chapter (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8178) 8178
biological and medical sciences (7407) 7407
medical sciences (7406) 7406
science & technology (7124) 7124
life sciences & biomedicine (7098) 7098
gastroenterology. liver. pancreas. abdomen (7027) 7027
stomach. duodenum. small intestine. colon. rectum. anus (6993) 6993
tumors (6578) 6578
male (5299) 5299
female (5189) 5189
middle aged (4531) 4531
oncology (4526) 4526
aged (4111) 4111
adult (3372) 3372
colorectal cancer (2072) 2072
pharmacology. drug treatments (2030) 2030
antineoplastic combined chemotherapy protocols - therapeutic use (1812) 1812
cancer (1755) 1755
treatment outcome (1705) 1705
antineoplastic agents (1691) 1691
aged, 80 and over (1670) 1670
colorectal neoplasms - drug therapy (1622) 1622
colorectal neoplasms - pathology (1461) 1461
surgery (1301) 1301
chemotherapy (1298) 1298
gastroenterology & hepatology (1256) 1256
fluorouracil - administration & dosage (1251) 1251
prognosis (1235) 1235
neoplasm staging (1092) 1092
medicine & public health (1074) 1074
abridged index medicus (1038) 1038
care and treatment (941) 941
animals (917) 917
stomach neoplasms - drug therapy (882) 882
combined modality therapy (877) 877
retrospective studies (877) 877
research (861) 861
stomach neoplasms - pathology (855) 855
antineoplastic agents - therapeutic use (798) 798
cell line, tumor (783) 783
disease-free survival (771) 771
adenocarcinoma - drug therapy (770) 770
risk factors (748) 748
pharmacology & pharmacy (744) 744
survival analysis (734) 734
follow-up studies (719) 719
survival rate (716) 716
colonic neoplasms - drug therapy (712) 712
colorectal neoplasms - genetics (706) 706
gastric cancer (685) 685
chemotherapy, adjuvant (683) 683
antineoplastic combined chemotherapy protocols - adverse effects (672) 672
mice (672) 672
anus neoplasms - drug therapy (659) 659
colon cancer (654) 654
colonic neoplasms - pathology (638) 638
other diseases. semiology (638) 638
camptothecin - analogs & derivatives (631) 631
multiple tumors. solid tumors. tumors in childhood (624) 624
analysis (617) 617
immunohistochemistry (582) 582
adenocarcinoma - pathology (572) 572
neoplasm metastasis (556) 556
fluorouracil - therapeutic use (551) 551
prospective studies (548) 548
leucovorin - administration & dosage (547) 547
metastasis (542) 542
gastroenterology (521) 521
colorectal neoplasms - mortality (510) 510
organoplatinum compounds - administration & dosage (505) 505
general aspects (495) 495
antineoplastic combined chemotherapy protocols - administration & dosage (481) 481
stomach cancer (481) 481
health aspects (480) 480
rectal neoplasms - drug therapy (475) 475
time factors (475) 475
camptothecin - administration & dosage (474) 474
apoptosis (470) 470
liver neoplasms - secondary (460) 460
colorectal neoplasms - metabolism (450) 450
anus neoplasms - pathology (442) 442
oncology, experimental (441) 441
cancer research (440) 440
drug administration schedule (440) 440
apoptosis - drug effects (438) 438
anus neoplasms - radiotherapy (433) 433
disease progression (411) 411
drug therapy (411) 411
fluorouracil - adverse effects (391) 391
rectal neoplasms - surgery (389) 389
mutation (387) 387
dose-response relationship, drug (384) 384
internal medicine (382) 382
radiotherapy (376) 376
rectal neoplasms - pathology (374) 374
rectal neoplasms - radiotherapy (363) 363
antineoplastic agents - pharmacology (361) 361
deoxycytidine - analogs & derivatives (350) 350
oxaliplatin (349) 349
pharmacology/toxicology (348) 348
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8317) 8317
French (55) 55
German (37) 37
Japanese (35) 35
Spanish (15) 15
Italian (12) 12
Russian (9) 9
Portuguese (5) 5
Danish (4) 4
Czech (3) 3
Norwegian (2) 2
Chinese (1) 1
Dutch (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial
by Jin Li and Shukui Qin and Jianming Xu and Weijian Guo and Jianping Xiong and Yuxian Bai and Guoping Sun and Yan Yang and Liwei Wang and Nong Xu and Ying Cheng and Zhehai Wang and Leizhen Zheng and Min Tao and Xiaodong Zhu and Dongmei Ji and Xin Liu and Hao Yu
Journal of clinical oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26, pp. 3219 - 3225
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Stomach Neoplasms - pathology | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Young Adult | Peritoneal Neoplasms - drug therapy | Lung Neoplasms - secondary | Adult | Female | Liver Neoplasms - secondary | Peritoneal Neoplasms - secondary | Pyridines - therapeutic use | Double-Blind Method | Liver Neoplasms - drug therapy | Survival Rate | Stomach Neoplasms - drug therapy | Peritoneal Neoplasms - mortality | International Agencies | Adolescent | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
by Loupakis, Fotios and Cremolini, Chiara and Masi, Gianluca and Lonardi, Sara and Zagonel, Vittorina and Salvatore, Lisa and Cortesi, Enrico and Tomasello, Gianluca and Ronzoni, Monica and Spadi, Rosella and Zaniboni, Alberto and Tonini, Giuseppe and Buonadonna, Angela and Amoroso, Domenico and Chiara, Silvana and Carlomagno, Chiara and Boni, Luca and Boni, Corrado and Allegrini, Giacomo and Falcone, Alfredo
The New England journal of medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | General aspects | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Immunomodulators | Tumors | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A Subpopulation of CD26 + Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
by Pang, Roberta and Law, Wai Lun and Chu, Andrew C.Y and Poon, Jensen T and Lam, Colin S.C and Chow, Ariel K.M and Ng, Lui and Cheung, Leonard W.H and Lan, Xiao R and Lan, Hui Y and Tan, Victoria P.Y and Yau, Thomas C and Poon, Ronnie T and Wong, Benjamin C.Y
Cell stem cell, ISSN 1934-5909, 2010, Volume 6, Issue 6, pp. 603 - 615
STEMCELL | CELLCYCLE | Cell & Tissue Engineering | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Fundamental and applied biological sciences. Psychology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Cell differentiation, maturation, development, hematopoiesis | Biological and medical sciences | Cell physiology | Molecular and cellular biology | Medical sciences | Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes | Tumors | Neoplasm Transplantation | RNA, Small Interfering - genetics | Prognosis | Follow-Up Studies | Apoptosis - drug effects | Neoplastic Stem Cells - drug effects | Colorectal Neoplasms - genetics | Humans | Apoptosis - genetics | Gene Expression Profiling | Colorectal Neoplasms - diagnosis | Organoplatinum Compounds - pharmacology | Neoplastic Stem Cells - metabolism | Cell Transformation, Neoplastic - genetics | Colorectal Neoplasms - drug therapy | Liver Neoplasms - physiopathology | Neoplastic Stem Cells - pathology | Tumor Burden - genetics | Tumor Cells, Cultured | Liver Neoplasms - secondary | Colorectal Neoplasms - metabolism | Carcinoma - secondary | Carcinoma - drug therapy | Liver Neoplasms - genetics | Dipeptidyl Peptidase 4 - biosynthesis | Liver Neoplasms - drug therapy | Carcinoma - diagnosis | Dipeptidyl Peptidase 4 - genetics | Mice, SCID | Carcinoma - physiopathology | Disease Progression | Colorectal Neoplasms - physiopathology | Drug Resistance, Neoplasm - genetics | Animals | Liver Neoplasms - diagnosis | Tumor Burden - drug effects | Liver Neoplasms - metabolism | Carcinoma - genetics | Biomarkers, Tumor - genetics | Fluorouracil - pharmacology | Mice | Carcinoma - metabolism | Colorectal Neoplasms - pathology | Neoplasm Invasiveness - genetics | Cell Migration Assays | Biomarkers, Tumor - biosynthesis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Neoadjuvant Cisplatin Chemotherapy Before Chemoradiation: A Flawed Paradigm?
by Rob Glynne-Jones and Peter Hoskin
Journal of clinical oncology, ISSN 0732-183X, 11/2007, Volume 25, Issue 33, pp. 5281 - 5286
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Uterine Cervical Neoplasms - radiotherapy | Humans | Head and Neck Neoplasms - drug therapy | Lung Neoplasms - radiotherapy | Neoplasms - mortality | Uterine Cervical Neoplasms - drug therapy | Antineoplastic Agents - therapeutic use | Esophageal Neoplasms - radiotherapy | Urinary Bladder Neoplasms - drug therapy | Neoplasms - drug therapy | Head and Neck Neoplasms - radiotherapy | Urinary Bladder Neoplasms - radiotherapy | Cisplatin - therapeutic use | Anus Neoplasms - drug therapy | Anus Neoplasms - radiotherapy | Female | Neoadjuvant Therapy | Neoplasms - radiotherapy | Carcinoma, Non-Small-Cell Lung - drug therapy | Chemotherapy, Adjuvant | Esophageal Neoplasms - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
by Enric Domingo and David N. Church and Oliver Sieber and Rajarajan Ramamoorthy and Yoko Yanagisawa and Elaine Johnstone and Brian Davidson and David J. Kerr and Ian P.M. Tomlinson and Rachel Midgley
Journal of clinical oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 34, pp. 4297 - 4305
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Colorectal Neoplasms - surgery | Multivariate Analysis | Sulfones - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Colectomy | Neoplasm Recurrence, Local - enzymology | Patient Selection | Neoplasm Recurrence, Local - pathology | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Aspirin - therapeutic use | Chemotherapy, Adjuvant | Colorectal Neoplasms - mortality | Colorectal Neoplasms - enzymology | Genetic Predisposition to Disease | Neoplasm Recurrence, Local - prevention & control | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Cyclooxygenase 2 - analysis | Lactones - therapeutic use | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Phenotype | Class I Phosphatidylinositol 3-Kinases | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Mutation | Colorectal Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy
by Ferrero, V T and Oset, M M and Masferrer, J P and Pardo, E H and Sorolla, E J and Largo, S C and PrevaDIOR Study Grp and PrevaDIOR Study Group and the PrevaDIOR Study Group
Clinical & translational oncology, ISSN 1699-048X, 12/2019, Volume 21, Issue 12, pp. 1707 - 1711
Breakthrough pain | Oncology | Pelvic 3D radiotherapy | Medicine & Public Health | Proctalgia | Life Sciences & Biomedicine | Science & Technology | Endometrial Neoplasms - radiotherapy | Prostatic Neoplasms - radiotherapy | Prevalence | Pain - epidemiology | Humans | Middle Aged | Breakthrough Pain - epidemiology | Male | Breakthrough Pain - drug therapy | Pain - drug therapy | Aged, 80 and over | Adult | Female | Neoplasms - radiotherapy | Rectal Neoplasms - drug therapy | Breakthrough Pain - etiology | Prostatic Neoplasms - drug therapy | Radiotherapy Dosage | Cancer Pain - epidemiology | Uterine Cervical Neoplasms - radiotherapy | Cross-Sectional Studies | Rectal Diseases - drug therapy | Urinary Bladder Neoplasms - drug therapy | Chi-Square Distribution | Rectal Neoplasms - radiotherapy | Neoplasms - drug therapy | Cancer Pain - drug therapy | Urinary Bladder Neoplasms - radiotherapy | Anus Neoplasms - drug therapy | Spain - epidemiology | Anus Neoplasms - radiotherapy | Cancer Pain - etiology | Rectal Diseases - epidemiology | Radiotherapy, Conformal - adverse effects | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
by Misale, Sandra and Yaeger, Rona and Hobor, Sebastijan and Scala, Elisa and Janakiraman, Manickam and Liska, David and Valtorta, Emanuele and Schiavo, Roberta and Buscarino, Michela and Siravegna, Giulia and Bencardino, Katia and Cercek, Andrea and Chen, Chin-Tung and Veronese, Silvio and Zanon, Carlo and Sartore-Bianchi, Andrea and Gambacorta, Marcello and Gallicchio, Margherita and Vakiani, Efsevia and Boscaro, Valentina and Medico, Enzo and Weiser, Martin and Siena, Salvatore and Di Nicolantonio, Federica and Solit, David and Bardelli, Alberto
Nature (London), ISSN 0028-0836, 06/2012, Volume 486, Issue 7404, pp. 532 - 536
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Immunotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | ErbB Receptors - antagonists & inhibitors | Antibodies, Monoclonal - pharmacology | Colorectal Neoplasms - genetics | Humans | Panitumumab | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Antibodies, Monoclonal - therapeutic use | Proto-Oncogene Proteins - genetics | Mutation - genetics | Promoter Regions, Genetic - genetics | Disease Progression | Antibodies, Monoclonal, Humanized | Drug Resistance, Neoplasm - genetics | Colorectal Neoplasms - drug therapy | Alleles | Cell Line, Tumor | Cetuximab | Colorectal Neoplasms - pathology | Drug Resistance, Neoplasm - drug effects | Genes, ras - genetics | Proteins | Cloning | Mutation | Kinases | Experiments | Cancer therapies | Mass spectrometry | Index Medicus | targeted therapy | KRAS | colorectal cancer | acquired resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
by Santini, D and Vincenzi, B and Addeo, R and Garufi, C and Masi, G and Scartozzi, M and Mancuso, A and Frezza, A.M and Venditti, O and Imperatori, M and Schiavon, G and Bronte, G and Cicero, G and Recine, F and Maiello, E and Cascinu, S and Russo, A and Falcone, A and Tonini, G
Annals of oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue 9, pp. 2313 - 2318
clinical trial | phase II | cetuximab | colorectal neoplasms | retreatment | Retreatment | Clinical trial | Phase II | Colorectal neoplasms | Cetuximab | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Liver Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Antibodies, Monoclonal, Humanized | Lung Neoplasms - secondary | Exanthema - chemically induced | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Treatment Outcome | Lymphatic Metastasis | Disease-Free Survival | Irinotecan | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Prognostic and predictive values of the immunoscore in patients with rectal cancer
by Anitei, Maria-Gabriela and Zeitoun, Guy and Mlecnik, Bernhard and Marliot, Florence and Haicheur, Nacilla and Todosi, Ana-Maria and Kirilovsky, Amos and Lagorce, Christine and Bindea, Gabriela and Ferariu, Dan and Danciu, Mihai and Bruneval, Patrick and Scripcariu, Viorel and Chevallier, Jean-Marc and Zinzindohoué, Franck and Berger, Anne and Galon, Jérôme and Pagès, Franck
Clinical cancer research, ISSN 1078-0432, 04/2014, Volume 20, Issue 7, pp. 1891 - 1899
Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Radiotherapy Dosage | Neoplasm Recurrence, Local - radiotherapy | Prognosis | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Lymphatic Metastasis - immunology | Male | Treatment Outcome | Combined Modality Therapy | Rectal Neoplasms - radiotherapy | Neoplasm Recurrence, Local - immunology | Neoplasm Recurrence, Local - pathology | Biopsy | Lymphatic Metastasis - pathology | CD3 Complex - immunology | Aged, 80 and over | Female | Aged | Rectal Neoplasms - pathology | CD8-Positive T-Lymphocytes - immunology | Neoplasm Staging | Rectal Neoplasms - drug therapy | Rectal Neoplasms - immunology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
by Missiaglia, E and Jacobs, B and D'Ario, G and Di Narzo, A.F and Soneson, C and Budinska, E and Popovici, V and Vecchione, L and Gerster, S and Yan, P and Roth, A.D and Klingbiel, D and Bosman, F.T and Delorenzi, M and Tejpar, S
Annals of oncology, ISSN 0923-7534, 10/2014, Volume 25, Issue 10, pp. 1995 - 2001
oncogenic pathways | mutations | colon cancer | expression profiling | survival | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Colonic Neoplasms - genetics | Microsatellite Instability | Prognosis | Neoplasm Proteins - biosynthesis | Colonic Neoplasms - drug therapy | Humans | Translational Medical Research | Neoplasm Recurrence, Local - drug therapy | Male | DNA Copy Number Variations - genetics | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Neoplasm Metastasis | Colonic Neoplasms - pathology | Female | Neoplasm Recurrence, Local - genetics | Neoplasm Proteins - genetics | Neoplasm Staging | Gene Expression Regulation, Neoplastic - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection
by Wong, R and Cunningham, D and Barbachano, Y and Saffery, C and Valle, J and Hickish, T and Mudan, S and Brown, G and Khan, A and Wotherspoon, A and Strimpakos, A.S and Thomas, J and Compton, S and Chua, Y.J and Chau, I
Annals of oncology, ISSN 0923-7534, 09/2011, Volume 22, Issue 9, pp. 2042 - 2048
bevacizumab | capecitabine | oxaliplatin | colorectal cancer | liver metastases | Liver metastases | Oxaliplatin | Capecitabine | Colorectal cancer | Bevacizumab | Life Sciences & Biomedicine | Oncology | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Colorectal Neoplasms - surgery | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Colorectal Neoplasms - therapy | Organoplatinum Compounds - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Risk Factors | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Adenocarcinoma - therapy | Perioperative Care - methods | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Adenocarcinoma - surgery | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights